Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen
Rare diseases: drug re-discovery Canadian researchers use three different approaches to identify drugs that could be repurposed to treat rare genetic diseases. Prompted by the growing gap between known rare diseases and therapies and postulating that diseases might be treated with drugs that modulat...
Guardado en:
Autores principales: | A. J. Mears, S. C. Schock, J. Hadwen, S. Putos, D. Dyment, K. M. Boycott, Alex MacKenzie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d2784f19fee4e1ebd89fab035bb9d11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs.
por: Farida S Akhtari, et al.
Publicado: (2021) -
Circadian regulation of the Drosophila astrocyte transcriptome.
por: Samantha You, et al.
Publicado: (2021) -
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
por: Kyrillus S. Shohdy, et al.
Publicado: (2021) -
Rare variants regulate expression of nearby individual genes in multiple tissues.
por: Jiajin Li, et al.
Publicado: (2021) -
Rare and common regulatory variation in population-scale sequenced human genomes.
por: Stephen B Montgomery, et al.
Publicado: (2011)